Explore the latest updates and key analyses on companies, markets, and industry trends.
Entero Therapeutics, Inc. Announces Reverse Stock Split
Entero Therapeutics, Inc. (ENTO) | August 14, 2025
By Victor Perez
Entero Therapeutics, Inc. announced a 1 for 3 reverse stock split of its common stock.
The reverse stock split aims to regain compliance with Nasdaq listing requirements.
Following the split, the number of outstanding common stock shares will reduce significantly.
Reverse Stock Split
Company to effect a 1 for 3 reverse stock split to enhance shareholder value.
Compliance Measure
Step taken to meet Nasdaq listing requirement of minimum bid price per share.
CEO's Comment
Interim CEO Richard Paolone sees the split as vital for maintaining Nasdaq listing visibility.
The reverse stock split will consolidate shares and streamline the company's capital structure.
Shareholders will see a reduction in the total number of outstanding shares post-split.
The reverse stock split shows Entero Therapeutics' commitment to meeting regulatory standards and increasing shareholder value. It signifies a strategic move towards maintaining a strong market presence.
